Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, open study of either etanercept or tofacitinib in patients with severe rheumatoid arthritis (RA)

Trial Profile

A randomized, open study of either etanercept or tofacitinib in patients with severe rheumatoid arthritis (RA)

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2018

At a glance

  • Drugs Etanercept (Primary) ; Tofacitinib (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jul 2018 New trial record
    • 16 Jun 2018 Results evaluating efficacy of Tofacitinib vs Etanercept in rheumatoid arthtritis patients (n=30) were presented at the 19th Annual Congress of the European League Against Rheumatism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top